chrisvoncsefalvay/vaers-outcomes huggingface dataset:
increased symptoms in 7 months which was not horrible but was progressing; diagnosed with Tentative Parkinson's Syndrome; This is a spontaneous report from a contactable consumer (patient) or other non healthcare professional. A 69-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection with Lot Number: EN6203), via an unspecified route of administration on 03Mar2021 as DOSE 1, SINGLE (age at the vaccination was 69-year-old) and the patient received second dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection with Lot Number: ER2613) via an unspecified route of administration on 24Mar2021 as DOSE 2, SINGLE for COVID-19 immunisation. The patient had no medical history and there were no concomitant medications. The patient was not if the reaction was to the first or second, but it started 2 weeks after the second. The patient stated that he started to develop what he thought was Parkinson's syndrome. The patient had the vaccine in Mar2021 and was diagnosed with tentative Parkinson's Syndrome on an unknown date Apr2021. The patient had an appointment with a respected hospital. The patient saw his primary care physician, a neurologist, and a rheumatologist. His question to everyone, some of the appointments were on an unknown dated June or July, was when the booster was available is it recommended to get the booster with the tentative Parkinson's Diagnosis in on an unknown dated Apr2021 It had gotten worse. It has progressed over the 7 months. The patient was in a high-risk category. The patient was 7 months past the second shot. The patient doesn't want to stay hibernated in his house. The patient would like to be able to see his children. The patient stated that he had seen doctors over the last 7 months and had been in contact with them through email and asked them specifically about his condition as he had increased symptoms in 7 months which was not horrible but was progressing. The patient wanted to know if this was a reported side effect with the vaccine and how it progresses as his doctors had no data and referred him to call Pfizer. The events outcome was reported as not recovered.  These adverse reactions have been identified during post authorization use of Pfizer-BioNTech COVID-19 Vaccine. Because these reactions are reported voluntarily, it was not always possible to reliably estimate their frequency or establish a causal relationship to vaccine exposure.
The patient puked 2 minutes after receiving the vaccine. She had the same reaction with the first shot.
Breakthrough case admission after three vaccines  Moderna 4/13/21 Lot# 038B21A;  Moderna 5/11/21 Lot# 033C21A;  Moderan 11/12/21 Lot#058F21A
I got the vaccine on friday 1/22/21.The next day I had a small red rash where the vaccine was administered. A few days later it got to be about the size of a baseball. It started to go away 4borb5 days after It started. A little over a week later 1/31/21 it started to come back. At first it was really sore now it just itchs
15 weeks pregnant; This spontaneous prospective pregnancy case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of EXPOSURE DURING PREGNANCY (15 weeks pregnant) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20-2A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use. Concurrent medical conditions included Seasonal allergy.    On 04-Jan-2021 at 10:07 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 17-Sep-2020 and the estimated date of delivery was 24-Jun-2021. On 04-Jan-2021 at 10:07 AM, the patient experienced EXPOSURE DURING PREGNANCY (15 weeks pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fifteenth week of the pregnancy.  On 04-Jan-2021, EXPOSURE DURING PREGNANCY (15 weeks pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Oct-2020, Pregnancy test: positive positive; estimated date of conception 04Oct2020.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator o No treatment medications provided by the reporter.    Most recent FOLLOW-UP information incorporated above includes: On 08-Jan-2021: No specific follow-up information recorded.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
Injection given 12:45pm 11-30-20, patient woke at midnight with sore arm and took Tylenol, it did not help. Tuesday 12-1-20 she had chills, fever, joint pain, and nausea.  She took ibuprofen three times that day and it helped. Wednesday 12-2-20 the fever, chills, aches and nausea were gone, but now she has hives, itching and swelling at injection site.  She took Benadryl 12-2-20 in the evening and it helped the itching. Patient called the pharmacy 3pm 12-3-20 about the reaction. She was advised to continue the Benadryl and call her primary care provider.
Information has been received from a health worker (medical assistant) regarding patients of unknown age and gender. No information about medical history, concurrent conditions were reported for the patient. Since 31-DEC-2014, improperly stored ROTATEQ liquid (strength and dose were not reported) lot K008140, expiration date 30-MAR-2016 were administered to unspecified patients. No adverse effects were reported. The outcome of the events reported were unknown. This case is linked to the cases 1503USA006428, 1502USA000168 via same reporter link. Additional information has been requested.
A pharmacist reported that a 70 year old female received an injection of Pnu-Imune 23 on 01/30/01. Within 1 day of  vaccine administration,the patient developed an injection site reaction characterized by redness, swelling, warmth, and tenderness. She was treated "symptomatically". This is 1 of 2 patients from this facility who experienced this event following receipt of Pnu-Imune 23 lot 469-132. Follow-up info received on 06/06/01 indicated that the patient recovered.
Patient is 45 yo female s/p full Pfizer COVID vaccination: dose 1 on 3/27 and dose 2 on 4/17. Pt is an employee at this institution and reports new onset cough, fatigue, and congestion/runny nose on 7/30. Patient also report known exposure to COVID-19. Rapid test results back positive on 7/30.
Patient suffered from redness and swelling on her right arm localized at the injection site for a few days
About 3 and 1/2  hours after receiving the 3 vaccines she fainted. She was completely unconscious for about 15 seconds. When she woke up she said her head hurt, she was hot and she felt weak. She did hit her head when she fell. She said right before she suddenly felt very tired and then remembered waking up. Only other symptoms were pain in each arm from injections. An ambulance was called and they said everything looked ok and she felt better. Since then she's had no other symptoms besides slight pain in her arms.
Patient called stating that she received the Moderna vaccine on 01/06/2021 in right arm. Stated that on 1/7/21 there was a hard lump at the injection site with a little redness. Today, 1/8/21, there is a "blotchy, red rash" lower on her arm that is itchy. She has used Benadryl for itching with some relief.
Guillain Barre' Syndrome. Tingling, numbness, weakness in extremities within 2 days of flu vaccine. Within one week, complete paralysis, respirator, blood transfusion, feed tube, tracheotomy, catheter, tracheotomy, intravenous immunoglobulum treatments. Physical therapy, Occupational therapy, Speech therapy.
chills; nausea; very severe head and neck pain; very severe head and neck pain; very  very weak; could not sleep/it also disturbed her sleep; exhausted the whole day; fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), CHILLS (chills), NAUSEA (nausea), HEADACHE (very severe head and neck pain) and NECK PAIN (very severe head and neck pain) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 037B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced PYREXIA (fever). On an unknown date, the patient experienced CHILLS (chills), NAUSEA (nausea), HEADACHE (very severe head and neck pain), NECK PAIN (very severe head and neck pain), ASTHENIA (very  very weak), INSOMNIA (could not sleep/it also disturbed her sleep) and FATIGUE (exhausted the whole day). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, PYREXIA (fever), CHILLS (chills), NAUSEA (nausea), HEADACHE (very severe head and neck pain), NECK PAIN (very severe head and neck pain), ASTHENIA (very  very weak) and INSOMNIA (could not sleep/it also disturbed her sleep) outcome was unknown. Not Provided          This case was linked to MOD-2021-097667 (Patient Link).   Reporter did not allow further contact
Patient had chills, nausea, weakness and headache for 72 hours after vaccine. she had previously had covid 19 infection in 11/2020. she did not receive any counselling on side effects of vaccine or that no studies were done on previously vaccinated persons.
Patient was diagnosed with Covid-19 PNA 01/13/2022.  Family found patient in bed at approximately 0959 the morning of 1/16/2022 and called 911.  Fire department began CPR, but efforts were stopped when EMS arrived as patient asystole and unknown downtime.
NA received the vaccine in his arm. His head dropped to his chest and was unresponsive for several seconds. He woke up on his own. The immunizing pharmacist had him put his feet up on another chair. She gave him juice to drink and a protein bar. 911 was called but he kept stating that he was feeling better. He stayed for about 30 minutes and then he left. the 911 call for ems was cancelled.
Fatigue; chills; hot flashes; sore arm; nerve pain; tingling in arm; This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the patient.  A 19 year-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 17Apr2021 11:45 (Lot number: ewol64) at the age of 19 years as dose 1, single for Covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing). Concomitant medication included: ALBUTEROL SULFATE. The following information was reported: FATIGUE (non-serious) with onset 17Apr2021, outcome "recovering", described as "Fatigue"; CHILLS (non-serious) with onset 17Apr2021, outcome "recovering", described as "chills"; HOT FLUSH (non-serious) with onset 17Apr2021, outcome "recovering", described as "hot flashes"; PAIN IN EXTREMITY (non-serious) with onset 17Apr2021, outcome "recovering", described as "sore arm"; NEURALGIA (non-serious) with onset 17Apr2021, outcome "recovering", described as "nerve pain"; PARAESTHESIA (non-serious) with onset 17Apr2021, outcome "recovering", described as "tingling in arm". Therapeutic measures were not taken as a result of fatigue, chills, hot flush, pain in extremity, neuralgia, paraesthesia. Additional Information: Patient has no other vaccine within four weeks. Patient did not tested for COVID since vaccination. Patient has no known allergies.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021532882 same patient/drug, different dose number/events
Large red circle around injection site, one week after injection. Painful, itchy, feels swollen
I got ill the next night, extreme vertigo, muscle weakness, leg nerve pain in both legs, very heavy menstrual cycle. The blood during my period was very black. I been on birth control for 20 years and this has never happen at all. I had a lot of twitching for a couple months, it end in April 2021. My cycles are still the same. I still have the weakness but not as bad as the beginning of January 2021.
Patient received Moderna booster. After 30 minutes waiting, she said it "felt like a lump was in her  throat and it was hard to swallow." She denied SOB. No trouble breathing. She was given Benadryl 50mg by mouth at 10:42 am. After waiting an additional 30 minutes, patient stated her symptoms have 'minimized."
About 1 min after shot given donor complained of dizziness.  Donor became pale and loss of consciousness occurred for 5 seconds. Donor then regained consciousness and water was given and donor felt fine.
Shoulder still hurts more than 8 weeks after shot. Patient states that she thinks it's because the shot was given too close to the shoulder. Her ortho thinks so.
Subject reports pain in R shoulder radiating from injection site. He also reports pain and decreased ROM in R shoulder as well as pain and warmth over deltoid R arm area. Subject has recovered.
Patient said she could not see and her ears were ringing about 5 minutes after the shot. It lasted about 10 seconds. We took the patients vitals and had her lay down for 15 min.
Fatigue; Headache; Dizziness; Dose number:3; This is a spontaneous report from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 32-year-old male patient received bnt162b2 (COMIRNATY), intramuscular, administered in right arm, administration date 28Nov2021 at 10:00 (Lot number: FH8027) at the age of 32 years as dose 3 (booster), single for COVID-19 immunisation. The patient had no relevant medical history. Concomitant medications were not reported. Vaccination history included: Comirnaty (DOSE 2, SINGLE, Lot Number: EL3247, Anatomical location: Left arm, Route of administration: Intramuscular), administration date: 09Feb2021, when the patient was 31 years old, and Comirnaty (DOSE 1, SINGLE, Lot Number: EL3247, Anatomical location: Right arm, Route of administration: Intramuscular), administration date: 19Jan2021, when the patient was 31 years old, for COVID-19 immunisation.  The following information was reported: IMMUNISATION (non-serious) with onset 28Nov2021 at 10:00, outcome "unknown", described as "Dose received: 3"; FATIGUE (non-serious) with onset 29Nov2021, outcome "recovering", described as "Fatigue"; HEADACHE (non-serious) with onset 29Nov2021, outcome "recovering", described as "Headache"; DIZZINESS (non-serious) with onset 29Nov2021, outcome "recovering", described as "Dizziness". Therapeutic measures were not taken as a result of fatigue, headache and dizziness.  Additional Information: The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.
Approximately five hours after the shot, I began to experience redness blotchy itchiness to my upper chest  and eye areas, then swelling.     My ears and scalp were also itchy.   The vaccine clinic doctors checked my throat and listened to my breathing.  They gave me 25mg of Benadryl and Tylenol.  While being monitored, a bad headache began behind my eyes and base of skull,  my throat became sore. The doctor  asked if I ever did albuterol, to which I said I carried an inhaler in case my breathing became difficult due to berry allergies or if I got sick, as I am pre-disposed to pneumonia and bronchitis.  I then took to puffs of the inhaler.  I was driven home and went to sleep.  By 9 pm, I had a severe, debilitating migraine headache, nausea, sensitivity to light and sound, which lasted until about 12:00 am, when through more ibuprofen, heat to my head, cool ac, and darkness, I fell asleep.  Upon waking up at 10 am, I was feeling okay, with a dull headache, however fatigued.  After resting the entire day, and taking Claritin and ibuprofen, I returned to work on Friday 3/5/2021.  At about 4 pm on Friday, I experienced a flare up of itchiness to my eyes, scalp and puffiness to my face and eyes.  I took another Claritin.
1/29/22 pt to hospital with worsening SOB; admitted with AHRF secondary to COVID Pulmonary Fibrosis; states had a positive COVID test on 1/5/22, PCP treated pt with Levaquin and steroid pack; transferred to ICU on 2/12/22 and required intubation; given high dose steroids; worsening ARDS/fibrosis; sepsis; ABX given; grim prognosis; pt made DNR with compassionate withdrawal of life support; pt expired in the hospital
Pt is 12 y Old boy who came in on 04/15/05 for a PE and was given MCV4 on R arm and there was no induration. 48 hours later pt developed a localized red, rash at upper arm and then progressed to include eyelids and entire upper arm on 23.5cm x 72.5 cm Given clindamycin and Benadryl, and ibuprofen.Pt had tenderness will f/u on 04/19/05.
Red, swollen, itchy rash around the site of the injection. Big round red rash.
At injection site: pain, swelling, redness, itching, lump, warm to touch
Patient received a monovalent booster after CDC bivalent recommendation was released on 9/1/22. Patient will be informed of error and offered bivalent vaccine per current CDC recommendations/timeline. Organizational safeguards have been implemented to prevent future recurrence.
feeling sick; diarrhea; This spontaneous case was reported by a patient and describes the occurrence of MALAISE (feeling sick) and DIARRHOEA (diarrhea) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).   On 30-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced MALAISE (feeling sick) and DIARRHOEA (diarrhea). At the time of the report, MALAISE (feeling sick) and DIARRHOEA (diarrhea) was resolving.            No relevant concomitant medications were reported. The patient said the lot number was unclear on the card. The patient did not receive any treatment. Action taken with mRNA-1273 in response to events was not applicable.
33 yr. old female noting right arm pain from injection site, referred pain down the lateral side of her left arm and into her hand as well as numbness in part of her hand and fingers. Afebrile, VSS Ext: left arm shows puncture site from SQ injection over left deltoid. Arm strength appears symmetrical and 4/5 in both arms. Grip strength is also symmetrical and 4/5 in both hands. Left arm is able to be fully extended up over head and behind back. No obvious reaction at the injection site. Reviewed the anatomy with her to show her where the major nerves are located in the upper arm and how far away they are from her injection site. She seemed very reassured by this. Recommend taking some Ibuprofen 600 mg every 8.
Swelling pain and redness at injection site with blister at injection site.  Left arm swollen hand to shoulder.  Left hand and elbow numbness and pain. Unable to use left arm until 48 hours past injection.  Headache for duration.
A 48 year old female, with medical history of allergy to thimerosal in contact solution, fibromyalgia, restless leg, and irritable bowel, had received an injection of influenza vaccine FLUZONE (lot number U1811AA) in her left deltoid on 19-Oct-2005. 3 days later, she experienced extreme dry noses, eyes, skin. Also mouth, lips, teeth and sinuses were dry. She stated past history of allergy to thimerosal in contact solution. On 02-Nov-05, i.e. 11 days after beginning of symptoms, she saw a physician as symptoms were still persisting. Patient's recovery status: not recovered. Follow up received on 06/Feb/2006 from a health care provider. The patient was examined by her physician on 03/Nov/2005 and had rhinitis and dry sinuses which he attributed to medications that she is currently taking. The date of vaccination is amended to 21/Oct/2005, and the onset of the adverse events is amended to 24/Oct/2005. Per the reporter, the physician stated that the patient is recovered and that her symptoms were not a result of the vaccination.
8 days later, swelling, redness, and slight pain at injection site - still ongoing on 11th day after injection. Those symptoms were not present for the first week after injection.
I received the 2 dose Pfizer vaccine on 10/3/21 and 10/25/21. The day after my 1st dose I experienced my heart rate increase, chest pains and fatigue. The day after I received my second dose , I woke up in the am panicing bc both my hands and both feet were tingling, burning, with a sensation of pins and needles. They also felt numb, as when your arm or leg falls asleep and is limp. I experienced twitching in my eye and my vision was very blurry. I had palpitations and my heart felt like it was racing out of my chest, and chest pains. I was extremely fatigued and my joints were very painful. I am still experiencing parasthesia in both my hands and both feet. I can't hold my phone or surface laptop for long periods of time because the sensations worsen when I do this. I have intermitent episodes of chest pains and my joint feel painful still have heavy fatigue.  I am setting up an appointment with a specialist in my area to consult with about my symptoms.
got sick; fever; chills; swollen lymph nodes under left arm pits; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 56-year-old male patient received BNT162b2 (BNT162B2), on 15Oct2021 at 08:00 as dose 3 (booster), single (Lot number: EW0196) at the age of 55 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Diabetes" (unspecified if ongoing); "Hypertension" (unspecified if ongoing). Concomitant medication(s) included: METFORMIN; TRADJENTA; LISINOPRIL; VIT D [COLECALCIFEROL]. Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: EL1284, Location of injection: Arm Left, Vaccine Administration Time: 08:30 AM), administration date: 28Dec2020, when the patient was 54-year-old, for Covid-19 Immunization; BNT162b2 (Dose Number: 2, Batch/Lot No: EL8982, Location of injection: Arm Left, Vaccine Administration Time: 08:00 AM), administration date: 15Jan2021, when the patient was 54-year-old, for Covid-19 Immunization. The following information was reported: ILLNESS (non-serious), outcome "recovering", described as "got sick"; PYREXIA (non-serious), outcome "recovering", described as "fever"; CHILLS (non-serious), outcome "recovering"; LYMPHADENOPATHY (non-serious), outcome "recovering", described as "swollen lymph nodes under left arm pits". The events "got sick", "fever" and "swollen lymph nodes under left arm pits" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: After third and fourth doses got sick and had fever and chills and developed swollen lymph nodes under left arm pits. Patient had no other vaccine in four weeks. Patient had no Covid prior vaccination and tested covid post vaccination. Patient had no known allergies.
The patient's wife called saying that her husband's left arm is so sore that he can not lift it. Also, he has been drinking an "excessive amount of water" since yesterday.
Patient received a sub-optimal COVID-19 vaccine due to a storage and handling error. Vaccine was stored in a freezer prior to being refrigerated and then administered. Requested that a VAERS form be submitted for this patient.